Novo Nordisk Pharmaceutical Industries, Inc.

novo nordisk is a leading global healthcare company, founded in 1923 and headquartered in denmark. our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. we do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. novo nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. for more information, visit novonordisk.com. this page isn’t intended for discussions about products. as such, postings or comments that contain product discussions may be removed. this page is for discussions about novo nordisk and its subsidiaries and the initiatives and projects we are involved in. while we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. any questions specific to products should be made to your healthcare professional. if you wish to file an adverse drug reaction please contact novo nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html for other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html please keep in mind that novo nordisk a/s and its subsidiaries work within a highly regulated industries. therefore, comments that pertain to legal matters or regulatory issues may be removed. comments contained on this site come from members of the public, and do not necessarily reflect the views of novo nordisk a/s. novo nordisk a/s does not endorse or approve any content added by other linkedin users. learn more about our privacy disclaimer and community guidelines here http://www.novonordisk.com/communityguidelines

E-posta adreslerini bulun

Tomba.io ile hızlıca deneyin. tomba.io.

Listeden e-posta adreslerini bulunGoogle'la başlayın